ID
45572
Beschrijving
Principal Investigator: Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000657 In this study, we used NGS to identify somatic events in advanced stage cancer patients to demonstrate the feasibility for using this approach to improve patient treatment.
Link
Trefwoorden
Versies (1)
- 24-01-23 24-01-23 - Dr. Christian Niklas
Houder van rechten
Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA
Geüploaded op
24 januari 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000657 NGS in Advanced Cancers
Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
Similar models
Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
C0441833 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])
C1516606 (UMLS CUI [1,2])